Our equality, diversity and inclusion strategy outlines a comprehensive approach to address disparities in genomic testing with a focus on equity and inclusion for all demographic groups. It emphasises the importance of increasing access to testing for underrepresented populations, fostering collaboration with key stakeholders, and support of organisations to promote diversity in genomic healthcare practice and research.
The strategy also prioritises data collection, workforce diversity, and research practices that reflect the true diversity of the population. It aims to ensure fair and inclusive access to genetic and genomics information, testing, and healthcare services across the Central and South region. The strategy is informed by collaborative efforts involving healthcare providers, patient advocacy groups, community organisations, and religious institutions. It also highlights the scientific necessity and ethical reasons for improving diversity in genomic research, emphasising the implications of genetic variations on health conditions.
The document defines Equality, Diversity, and Inclusion (EDI) and emphasises the importance of treating individuals fairly, recognising and valuing differences, and creating an inclusive environment. Overall, the strategy aims to dismantle barriers to equitable genomic health and ensure that every individual, regardless of background, has access to the potential benefits of genomic healthcare advancements and research.